Prevalence and Potential Mechanisms of Sustained Ventricular Arrhythmias During Dobutamine Stress Echocardiography: A Literature Review

Journal of the American Society of Echocardiography

Volumn 21, Issue 12, 2008, Pages 1376-1381

  Karabinos, Ilias ^a   Kranidis, Athanasios ^b   Papadopoulos, Anastasios ^a   Katritsis, Demosthenes ^a  

^a Athens Euroclinic ^*  (Greece)

^b EVANGELISMOS HOSPITAL   (Greece)

Author keywords

Dobutamine; Myocardial ischemia; Stress echocardiography; Ventricular fibrillation; Ventricular tachycardia

Indexed keywords

DOBUTAMINE;

HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; REVIEW; STRESS ECHOCARDIOGRAPHY;

CARDIOTONIC AGENTS; DOBUTAMINE; ECHOCARDIOGRAPHY; EXERCISE TEST; HUMANS; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; VENTRICULAR FIBRILLATION;

EID: 56549120880     PISSN: 08947317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.echo.2008.09.015     Document Type: Review

References (75)

1. Varga A., Garcia M.A., and Picano E. Safety of stress echocardiography (from the International Stress Echo Complication Registry). Am J Cardiol 98 (2006) 541-543
2. Sicari R., Nihoyannopoulos P., Evangelista A., Kasprzak J., Lancellotti P., Poldermans D., et al. Stress echocardiography expert consensus statement European Association of Echocardiography (EAE) (a registered branch of the ESC). Eur J Echocardiogr 9 (2008) 415-437
3. Mertes H., Sawada S.G., Ryan T., Segar D.S., Kovacs R., Foltz J., et al. Symptoms, adverse effects, and complications associated with dobutamine stress echocardiography. Experience in 1118 patients. Circulation 88 (1993) 15-19
4. Fetiveau R., Lanzarini L., Poli A., Diotallevi P., Mussini M.F., Montemartini C., et al. The side effects and safety of the echo-dobutamine test. The experience with 373 patients. G Ital Cardiol 25 (1995) 193-201
5. Picano E., Mathias Jr. W., Pingitore A., Bigi R., and Previtali M. Safety and tolerability of dobutamine-atropine stress echocardiography: a prospective, multicentre study: Echo Dobutamine International Cooperative Study Group. Lancet 344 (1994) 1190-1192
6. Pellikka P.A., Roger V.L., Oh J.K., Miller F.A., Seward J.B., Tajik A.J., et al. Stress echocardiography. Part II. Dobutamine stress echocardiography: techniques, implementation, clinical applications, and correlations. Mayo Clin Proc 70 (1995) 16-27
7. Cornel J.H., Balk A.H., Boersma E., Maat A.P., Elhendy A., Arnese M., et al. Safety and feasibility of dobutamine-atropine stress echocardiography in patients with ischemic left ventricular dysfunction. J Am Soc Echocardiogr 9 (1996) 27-32
8. Zahn R., Lotter R., Nohl H., Schiele R., Bergmeier C., Zander M., et al. Feasibility and safety of dobutamine stress echocardiography: experiences with 1,000 studies. Z Kardiol 85 (1996) 28-34
9. San Román J.A., Vilacosta I., Castillo J.A., Rollán M.J., Peral V., Sánchez-Harguindey L., et al. Dipyridamole and dobutamine-atropine stress echocardiography in the diagnosis of coronary artery disease. Comparison with exercise stress test, analysis of agreement, and impact of antianginal treatment. Chest 110 (1996) 1248-1254
10. Cladellas Capdevila M., Bruguera Cortada J., Hernández Herrero J., Villena Segura J., and Serrat Serradell R. Adverse effects of dobutamine stress echocardiography. Rev Esp Cardiol 49 (1996) 22-28
11. Secknus M.A., and Marwick T.H. Evolution of dobutamine echocardiography protocols and indications: safety and side effects in 3011studies over 5 years. J Am Coll Cardiol 29 (1997) 1234-1240 6
12. Elhendy A., van Domburg R.T., Roelandt J.R., Geleijnse M.L., Ibrahim M.M., and Fioretti P.M. Safety and feasibility of dobutamine-atropine stress testing in hypertensive patients. Hypertension 29 (1997) 1232-1239
13. Hennessy T.G., Codd M.B., Kane G., McCarthy C., McCann H.A., and Sugrue D.D. Safety of dobutamine stress echocardiography in 474 consecutive studies. Coron Artery Dis 8 (1997) 175-178
14. Pinton R., Lemke W., and Garcia L.G. Symptoms, complications and hemodynamic changes related to dobutamine stress echocardiography. Arq Bras Cardiol 69 (1997) 161-164
15. Mathias Júnior W., Beneti L.P., dos Santos F.C., Duprat R., Beraldo A., Gil M.A., et al. Safety and feasibility of dobutamine-atropine stress echocardiography. Arq Bras Cardiol 69 (1997) 31-34
16. Lamisse N., Cohen A., Chauvel C., Benhalima B., Désert I., Buyukoglu B., et al. Dobutamine stress echocardiography; a monocentric experience on 600 consecutive patients. Effect of age. Arch Mal Coeur Vaiss 90 (1997) 1455-1461
17. Elhendy A., van Domburg R.T., Bax J.J., and Roelandt J.R. Relation between the extent of coronary artery disease and tachyarrhythmias during dobutamine stress echocardiography. Am J Cardiol 83 (1999) 832-835
18. Pezzano A., Gentile F., Mantero A., Morabito A., and Ravizza P. RITED (Registro Italiano Test Eco-Dobutamina): side effects and complications of echo-dobutamine stress test in 3041 examinations. G Ital Cardiol 28 (1998) 102-111
19. Bremer M.L., Monahan K.H., Stussy V.L., Miller Jr. F.A., Seward J.B., and Pellikka P.A. Safety of dobutamine stress echocardiography supervised by registered nurse sonographers. J Am Soc Echocardiogr 11 (1998) 601-605
20. Płońska E., Szwed H., Gasior Z., Drozdz J., Gackowski A., Szyszka A., et al. Side effects during dobutamine stress echocardiography: analysis of 582 studies. Pol Merkur Lekarski 7 (1999) 164-168
21. Takeuchi M., Miura Y., Sonoda S., and Kuroiwa A. Comparison of three different protocols for dobutamine stress echocardiography: does the addition of atropine increase complications, and does it improve diagnostic accuracy?. Echocardiography 16 (1999) 347-355
22. Poldermans D., Fioretti P.M., Boersma E., Bax J., Thomson I., Roelandt J., et al. Long-term prognostic value of dobutamine-atropine stress echocardiography in 1737 patients with known or suspected coronary artery disease: a single-center experience. Circulation 99 (1999) 757-762
23. Mathias Jr. W., Arruda A., Santos F.C., Arruda A.L., Mattos E., Oso'rio A., et al. Safety of dobutamine-atropine stress echocardiography: a prospective experience of 4,033 consecutive studies. J Am Soc Echocardiogr 12 (1999) 785-791
24. Cortigiani L., Picano E., Coletta C., Chiarella F., Mathias W., Gandolfo N., et al., Echo Persantine International Cooperative (EPIC) Study Group; Echo Dobutamine International Cooperative (EDIC) Study Group. Safety, feasibility, and prognostic implications of pharmacologic stress echocardiography in 1482 patients evaluated in an ambulatory setting. Am Heart J 141 (2001) 621-629
25. Hirano Y., Yamamoto T., Uehara H., Nakamura H., Wufuer M., and Yamada S. Complications of stress echocardiography. J Cardiol 38 (2001) 73-80
26. João I., Cotrim C., do Rosário L., Duarte J.A., Freire G., Fazendas P., et al. Complications in stress echocardiography. Rev Port Cardiol 21 (2002) 871-881
27. Cortigiani L., Zanetti L., Bigi R., Desideri A., Fiorentini C., and Nannini E. Safety and feasibility of dobutamine and dipyridamole stress echocardiography in hypertensive patients. J Hypertens 20 (2002) 1423-1429
28. Persianov-Dubrov I.V., Alekhin M.N., Gogin G.E., Glezer M.G., and Sidorenko B.A. Safety of exercise and dobutamine stress echocardiography (results of 2383 tests). Kardiologiia 43 (2003) 18-22
29. Siddiqui T.S., and Stoddard M.F. Safety of dobutamine stress transesophageal echocardiography in obese patients for evaluation of potential ischemic heart disease. Echocardiography 21 (2004) 603-608
30. Tsutsui J.M., Osório A.F., Lario F.A., Fernandes D.R., Sodre G., Andrade J.L., et al. Comparison of safety and efficacy of the early injection of atropine during dobutamine stress echocardiography with the conventional protocol. Am J Cardiol 94 (2004) 1367-1372
31. Abreu J.S., Diógenes T.C., Farias A.G., Morais J.M., and Paes Júnior J.N. Safety and feasibility of dobutamine-atropine stress echocardiography in octogenarian patients. Arq Bras Cardiol 85 (2005) 198-204
32. Tsutsui J.M., Elhendy A., Xie F., O'Leary E.L., McGrain A.C., Porter T.R., et al. Safety of dobutamine stress real-time myocardial contrast echocardiography. J Am Coll Cardiol 45 (2005) 1235-1242
33. Katritsis D.G., Karabinos I.K., Papadopoulos A., Simeonidis P., Korovesis S., Giazitzoglou E., et al. Sustained ventricular tachycardia induced by dobutamine stress echocardiography: a prospective study. Europace 7 (2005) 433-439
34. Tsutsui J.M., Lario F.C., Fernandes D.R., Kowatsch I., Sbano J.C., Franchini Ramires J.A., et al. Safety and cardiac chronotropic responsiveness to the early injection of atropine during dobutamine stress echocardiography in the elderly. Heart 91 (2005) 1563-1567
35. Timperley J., Mitchell A.R., Thibault H., Mirza I.H., and Becher H. Safety of contrast dobutamine stress echocardiography: a single center experience. J Am Soc Echocardiogr 18 (2005) 163-167
36. Wejner-Mik P., Drozdz J., Lipiec P., Krzemińska-Pakuła M., Ciesielczyk M., and Kasprzak J.D. Prevalence of dangerous arrhythmia during pharmacological stress echocardiography. Pol Merkur Lekarski 20 (2006) 635-638
37. Aggeli C., Giannopoulos G., Roussakis G., Christoforatou E., Marinos G., Toli C., et al. Safety of myocardial flash-contrast echocardiography in combination with dobutamine stress testing for detection of ischemia in 5250 studies. Heart (2008) May 12. [Epub ahead of print]
38. Kane G.C., Hepinstall M.J., Kidd G.M., Kuehl C.A., Murphy A.T., Nelson J.M., et al. Safety of stress echocardiography supervised by registered nurses: results of a 2-year audit of 15,404 patients. J Am Soc Echocardiogr 21 (2008) 337-341
39. Mikheev N.N. Complications of stress-echocardiography used for diagnosis of ischemic heart disease. Kardiologiia 48 (2008) 19-23
40. San Román J.A., Sanz-Ruiz R., Ortega J.R., Pérez-Paredes M., Rollán M.J., Muñoz A.C., et al. Safety and predictors of complications with a new accelerated dobutamine stress echocardiography protocol. J Am Soc Echocardiogr 21 (2008) 53-57
41. Minardi G., Manzara C., Pulignano G., Pino P.G., Pavaci H., and Sordi M. Feasibility, safety and tolerability of accelerated dobutamine stress echocardiography. Cardiovasc Ultrasound 5 (2007) 40
42. Bountioukos M., Kertai M.D., Schinkel A.F., Vourvouri E.C., Rizzello V., Krenning B.J., et al. Safety of dobutamine stress echocardiography in patients with aortic stenosis. J Heart Valve Dis 12 (2003) 441-446
43. Bigi R., Partesana N., Verzoni A., Bandini P., Maffi M., Longoni A., et al. Incidence and correlates of complex ventricular arrhythmias during dobutamine stress echocardiography after acute myocardial infarction. Eur Heart J 16 (1995) 1819-1824
44. Smart S.C., Knickelbine T., Stoiber T.R., Carlos M., Wynsen J.C., and Sagar K.B. Safety and accuracy of dobutamine-atropine stress echocardiography for the detection of residual stenosis of the infarct-related artery and multivessel disease during the first week after acute myocardial infarction. Circulation 95 (1997) 1394-1401
45. Elhendy A., van Domburg R.T., Poldermans D., Bax J.J., Nierop P.R., Geleijnse M.L., et al. Safety and feasibility of dobutamine-atropine stress echocardiography for the diagnosis of coronary artery disease in diabetic patients unable to perform an exercise stress test. Diabetes Care 21 (1998) 1797-1802
46. Fujikawa H., Sato Y., Arakawa H., Mitsuhashi T., Minezaki K., Kuroki S., et al. Induction of torsades de pointes by dobutamine infusion in a patient with idiopathic long QT syndrome. Intern Med 37 (1998) 149-152
47. Varga A., Kraft G., Lakatos F., Bigi R., Paya R., and Picano E. Complications during pharmacological stress echocardiography: a video-case series. Cardiovascular Ultrasound 3 (2005) 25
48. Karabinos I., Papadopoulos A., Koulouris S., Kranidis A., Korovesis S., Katritsis D., et al. Spontaneous coronary artery dissection during a dobutamine stress echocardiography. Echocardiography 23 (2006) 232-234
49. Jiamsripong P., Honda T., McCully R., Khandheria B., and Mookadam F. Ventricular fibrillation in late recovery after dobutamine stress echocardiography. J Am Soc Echocardiogr 20 (2007) 1220.e7-1220.e10 Epub 2007 Jul 27
50. Sutter J., Poldermans D., Vourvouri E., Van Donburg R., Elhendy A., Bax J., et al. Long term prognostic significance of complex ventricular arrhythmias induced during dobutamine stress echocardiography. Am J Cardiol 91 (2003) 242-244
51. Stambler B.S., Akosah K.O., Mohanty P.K., Wood M.A., and Ellenbogen K.A. Myocardial ischemia and induction of sustained ventricular tachyarrhythmias: evaluation using dobutamine stress echocardiography-electrophysiologic testing. J Cardiovasc Electrophysiol 15 (2004) 901-907
52. Sung R.J., Shen E.N., Morady F., Scheinman M.M., Hess D., and Botvinick E.H. Electrophysiologic mechanism of exercise-induced sustained ventricular tachycardia. Am J Cardiol 51 (1983) 525-530
53. Wu D., Kou H.C., and Hung J.S. Exercise triggered paroxysmal ventricular tachycardia. A repetitive rhythmic activity possibly related to after depolarization. Ann Intern Med 95 (1981) 410-414
54. Marcus F.I., Cobb L.A., Edwards J.E., Kuller L., Moss A.J., Bigger J.T., et al. Mechanism of death and prevalence of myocardial ischemic symptoms in the terminal event after acute myocardial infarction. Am J Cardiol 61 (1988) 8-15
55. Palileo E.V., Ashley W.W., Swiryn S., Bauernfeind R.A., Strasberg B., Petropoulos A.T., et al. Exercise provocable right ventricular outflow tract tachycardia. Am Heart J 104 (1982) 185
56. Coma-Canella I. Changes in plasma potassium during the dobutamine stress test. Int J Cardiol 33 (1991) 55-59
57. Galloway M.T., Paglieroni T.G., Wun T., Arena F.J., and Lewis W.R. Platelet activation during dobutamine stress echocardiography. Am Heart J 135 (1998) 888-900
58. Nelson S.D., and Coyne K. Electrophysiologic effects of selective B1 adrenergic stimulation in the late phase of myocardial infarct healing. Int J Cardiol 36 (1992) 95-102
59. Wolfe C.L., Nibley C., Bhandari A., Chatterjee K., and Scheinman M. Polymorphous ventricular tachycardia associated with acute myocardial infarction. Circulation 84 (1991) 1543-1551
60. Sclarovsky S., Strasberg B., Lewin R.F., and Agmon J. Polymorphous ventricular tachycardia: clinical features and treatment. Am J Cardiol 44 (1979) 339
61. DeBakker J.M.T., Van Capelle G.J.L., Janse M.J., Wilde A.A., Coronel R., Becker A.E., et al. Reentry as a cause of ventricular tachycardia in patients with chronic ischemic heart disease: electrophysiologic and anatomic correlation. Circulation 77 (1988) 589-606
62. Mehta D., Curwin J., Gomes J.A., and Fuster V. Sudden death in coronary artery disease: acute ischemia versus myocardial substrate. Circulation 96 (1997) 3215-3223
63. Kelly P., Ruskin J.N., Vlahakes G.J., Buckley Jr. M.J., Freeman C.S., and Garan H. Surgical coronary revascularization in survivors of prehospital cardiac arrest: its effect on inducible ventricular arrhythmias and long-term survival. J Am Coll Cardiol 15 (1990) 267-273
64. Rasmussen K., Lunde P.I., and Lie M. Coronary bypass surgery in exercise induced ventricular tachycardia. Eur Heart J 8 (1987) 44
65. Furukawa T., Moroe K., Mayrovitz H.N., Sampsell R., Furukawa N., and Myerburg R.J. Arrhythmogenic effects of graded coronary blood flow reduction superimposed upon prior myocardial infarction in dogs. Circulation 84 (1991) 368-377
66. Garan H., McComb J.M., and Ruskin J.N. Spontaneous and electrically induced ventricular arrhythmias during acute ischemia superimposed on 2 week old canine myocardial infarction. J Am Coll Cardiol 11 (1988) 603-611
67. Young D.Z., Lampert S., Graboys T.B., and Lown B. Safety of maximal exercise testing in patients at high risk for ventricular arrhythmia. Circulation 70 (1984) 184-191
68. Vlay S.C. Catecholamine-sensitive ventricular tachycardia. Am Heart J 114 (1987) 455-461
69. Stuart Jr. R.J., and Ellestad M.H. National survey of exercise stress testing facilities. Chest 77 (1980) 94-97
70. Myers J., Voodi L., Umann T., and Froelicher V.F. A survey of exercise testing: methods, utilization, interpretation, and safety in the VAHCS. J Cardiopulm Rehabil 20 (2000) 251-258
71. Previtali M., Lanzarini L., Fetiveau R., Poli A., Ferrario M., Falcone C., et al. Comparison of dobutamine stress echocardiography, dipyridamole stress echocardiography and exercise stress testing for diagnosis of coronary artery disease. Am J Cardiol 72 (1993) 865-870
72. Elhendy A., Chandrasekaran K., Gersh B.J., Mahoney D., Burger K.N., and Pellikka P.A. Functional and prognostic significance of exercise-induced ventricular arrhythmias in patients with suspected coronary artery disease. Am J Cardiol 90 (2002) 95-100
73. Lette J., Tatum J.L., Fraser S., Miller D.D., Waters D.D., Heller G., et al. Safety of dipyridamole testing in 73806 patients: the Multicenter Dipyridamole Safety Study. J Nucl Cardiol 2 (1995) 3-17
74. Picano E., Marini C., Pirelli S., Maffei S., Bolognese L., Chiriatti G., et al. Safety of intravenous high-dose dipyridamole echocardiography. The Echo-Persantine International Cooperative Study Group. Am J Cardiol 70 (1992) 252-258
75. Marcassa C., Bax J., Bengel F., Hesse B., Petersen C., Reyes E., et al. Clinical value, cost-effectiveness, and safety of myocardial perfusion scintigraphy: a position statement. Eur Heart J 29 (2008) 557-563